|
SourceOne Stock Info Your one source site for
stock research |
||||||||||||
Investor RelationsWhat’s the buzz— message boards |
Sepracor Inc
SEPR Sepracor Inc. is a research-based pharmaceutical company involved in the research, development and commercialization of different products that serve unmet medical needs. Sepracor’s compounds are either single isomer or active-metabolite forms of existing drugs or new chemical entity compounds that are unrelated to marketed products. Sepracor is developing products in two therapeutic areas: respiratory and central nervous system disorders. It has also licensed its technology and patent rights to third parties. These out-licensing agreements include Schering-Plough Corporation for CLARINEX, sanofi-aventis for ALLEGRA and UCB Pharma for XYZAL/XUSAL. Sepracor manufactures and sells XOPENEX Inhalation Solution, a short-acting bronchodilator, for the treatment or prevention of asthma. Stock Quotes and Other InformationSearch
for Stocks: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Alphabetical
Listings by Company Name S&P
100 S&P
500 S&P
400 Dow Jones
Industrials Dow Jones Transportation Dow Jones
Utilities Dow Jones Composite Nasdaq 100 Morgan Stanley Hi-Tech 35 |
|
||||||||||